Belantamab mafodotin is a medication designed to treat multiple myeloma, a type of blood cancer. It works by targeting specific proteins on cancer cells to help destroy them while limiting damage to healthy cells.

Bortezomib is an anticancer medication that belongs to a class of drugs called proteasome inhibitors. It works by blocking certain proteins in cancer cells, which helps to slow or stop cancer cell growth. It’s commonly used in treating multiple myeloma.

Dexamethasone is a corticosteroid medication that helps reduce inflammation and suppress the immune system. In cancer treatment, it’s often used alongside other medications to help make them more effective and to help manage certain side effects of cancer therapy.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that help fight infections. In this condition, cancerous plasma cells accumulate in the bone marrow, crowding out healthy blood cells and producing abnormal proteins. The disease often affects multiple areas of the body, particularly the bones, leading to bone weakening. Multiple myeloma typically progresses through cycles of active disease and remission, with the relapsed/refractory form (RRMM) occurring when the disease returns or becomes resistant to previous treatments. The disease can affect various body systems, including the bones, kidneys, and blood cell production.